Strebi Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 13-12-2024
- Paid Up Capital ₹ 1.00 M
as on 13-12-2024
- Company Age 5 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 M
as on 13-12-2024
- Revenue 23.47%
(FY 2023)
- Profit 26.97%
(FY 2023)
- Ebitda -104.85%
(FY 2023)
- Net Worth 4.95%
(FY 2023)
- Total Assets 40.44%
(FY 2023)
About Strebi Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹1.00 M.
Nishtha Dhiman and Shweta Dhiman serve as directors at the Company.
- CIN/LLPIN
U24304HR2019PTC083195
- Company No.
083195
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Oct 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Yamuna Nagar, Haryana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Strebi Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shweta Dhiman  | Managing Director | 23-Oct-2019 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nishtha Dhiman | Director | 23-Oct-2019 | Current |
Financial Performance of Strebi Pharmaceuticals.
Strebi Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 23.47% increase. The company also saw a substantial improvement in profitability, with a 26.97% increase in profit. The company's net worth moved up by a moderate rise of 4.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Strebi Pharmaceuticals?
Unlock access to Strebi Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Idbi Bank Limited Creation Date: 17 Mar 2021 | ₹1.00 M | Open |
How Many Employees Work at Strebi Pharmaceuticals?
Unlock and access historical data on people associated with Strebi Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Strebi Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Strebi Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
